We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




System Offers Both Morphology Preservation and Biomolecule Stabilization

By LabMedica International staff writers
Posted on 02 Feb 2009
Print article
An integrated laboratory system for sample fixation, stabilization, and purification is available. The system allows scientists to perform histology, immunohistochemistry, and stabilized nucleic acid extractions from one sample without compromising workflow.

The system has two components: a tissue container and tissue kits. The dual-chambered container is prefilled with two reagents: a tissue fixative for fast penetration and fixation, and a tissue stabilizer for storage and transport. The fixation process uses a standard histocasette with a fixative that is an alternative to formalin and is stopped when the sample is transferred into the stabilizer. Fixation time is standardized at two to four hours.

The sample remains stable in the tissue stabilizer for transport and storage prior to processing. The tissue can then be paraffin embedded and processed in pathology workflows. After the tissue sample has been stabilized in tissue containers (and optionally paraffin embedded), ribonucleic acid (RNA), micro (mi)RNA, and DNA can be purified using tissue kits.

Laboratories working with human and animal tissue need to conduct a variety of analyses on limited sample materials. The recognized standard for preserving tissue morphology is formalin fixation/paraffin embedding (FFPE). This method provides excellent results for morphological studies, but it does not preserve biomolecules. As a result, the DNA, RNA, and miRNA molecules degrade, preventing the complete analysis required. This would hinder applications such as the development of diagnostics and therapeutics, biomarker discovery, and case-controlled and population-based clinical studies.

The technology, called the PAXgene tissue system, is the newest addition to Qiagen's (Frankfurt, Germany) suite of tissue management technologies. The suite includes integrated products that standardize all steps of the workflow, starting with archived or prospectively collected tissues and ending with data analysis. This ensures comparability and reproducibility of data from laboratory to laboratory.

Qiagen is a global provider of sample and assay technologies. Sample technologies are used to isolate and process nucleic acids and proteins from biologic samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutic, and biotechnology companies.

Related Links:

Qiagen



New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Hematocrit Centrifuge
4088M1 - Zip Compact
New
Sexually Transmitted Diseases Test
STD Panel Strip

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.